These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30027776)

  • 1. The concentration of total sialic acid in chronic hepatitis B and C.
    Gruszewska E; Cylwik B; Gudowska M; Panasiuk A; Flisiak R; Chrostek L
    Ann Clin Biochem; 2019 Jan; 56(1):118-122. PubMed ID: 30027776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Sialic Acid Concentration and Content in ApoB-Containing Lipoproteins in Liver Diseases.
    Gudowska M; Gruszewska E; Cylwik B; Panasiuk A; Filisiak R; Szmitkowski M; Chrostek L
    Clin Lab; 2016; 62(6):1069-74. PubMed ID: 27468569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.
    Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E
    Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of chronic alcohol drinking on the total concentration of sialic acid and lipid-bound sialic acid].
    Cylwik B; Krawiec A; Chrostek L; Supronowicz Z; Szmitkowski M
    Pol Merkur Lekarski; 2009 Aug; 27(158):101-4. PubMed ID: 19856873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients.
    Lapinski TW; Kowalczuk O; Prokopowicz D; Chyczewski L
    World J Gastroenterol; 2004 Dec; 10(24):3650-3. PubMed ID: 15534924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and free serum sialic acid concentration in liver diseases.
    Gruszewska E; Cylwik B; Panasiuk A; Szmitkowski M; Flisiak R; Chrostek L
    Biomed Res Int; 2014; 2014():876096. PubMed ID: 24959592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].
    Marek B; Kajdaniuk D; Janczewska-Kazek E; Beniowski M; Swietochowska E; Kos-Kudła B; Ostrowska Z; Mazurek U; Wilczok T; Nowak M; Siemińska L; Borgiel-Marek H; Strzyzewski A; Januła A; Sierek K; Niedzielski Z
    Pol Arch Med Wewn; 2003 Jun; 109(6):603-8. PubMed ID: 14567092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialic acid as a marker of pancreatic cancers.
    Gruszewska E; Chrostek L; Cylwik B; Tobolczyk J; Szmitkowski M; Kuklinski A; Kedra B
    Clin Lab; 2013; 59(7-8):781-8. PubMed ID: 24133906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patients.
    Orăşan OH; Sava M; Iancu M; Cozma A; Saplonţai-Pop A; Sarlea Ţărmure S; Lungoci C; Orăşan RA; Patiu IM; Dumitraşcu DL
    Int Urol Nephrol; 2015 Jul; 47(7):1209-17. PubMed ID: 26025064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection.
    Tsiomita S; Georgopoulou U; Doumba PP; Koskinas J; Adamidis K; Papaloukas C; Thyphronitis G
    Infect Genet Evol; 2018 Mar; 58():17-22. PubMed ID: 29221787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.
    Murawaki Y; Ikuta Y; Idobe Y; Kawasaki H
    J Gastroenterol Hepatol; 1999 Feb; 14(2):138-45. PubMed ID: 10029294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ischemic modified albumin (IMA) concentration and IMA/albumin ratio in patients with hepatitis B-related chronic liver diseases.
    Yavuz F; Biyik M; Asil M; Dertli R; Demir A; Polat H; Uysal S; Ataseven H
    Turk J Med Sci; 2017 Jun; 47(3):947-953. PubMed ID: 28618749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.
    Gokce O; Ozenirler S; Atak Yucel A; Oruklu N; Yilmaz Esendagli G; Karahan S
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):918-924. PubMed ID: 29683980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    Manolakopoulos S; Bethanis S; Liapi C; Stripeli F; Sklavos P; Margeli A; Christidou A; Katsanika A; Vogiatzakis E; Tzourmakliotis D; Theocharis S
    BMC Gastroenterol; 2007 May; 7():17. PubMed ID: 17540037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of autotaxin as a serum marker for liver fibrosis.
    Ikeda H; Kobayashi M; Kumada H; Enooku K; Koike K; Kurano M; Sato M; Nojiri T; Kobayashi T; Ohkawa R; Shimamoto S; Igarashi K; Aoki J; Yatomi Y
    Ann Clin Biochem; 2018 Jul; 55(4):469-477. PubMed ID: 29065699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free sialic acid as a marker of alcohol abuse.
    Chrostek L; Cylwik B; Korcz W; Krawiec A; Koput A; Supronowicz Z; Szmitkowski M
    Alcohol Clin Exp Res; 2007 Jun; 31(6):996-1001. PubMed ID: 17428294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain.
    Wu EB; Lumb P; Chambers JB; Crook MA
    Atherosclerosis; 1999 Aug; 145(2):261-6. PubMed ID: 10488951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
    Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
    Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
    Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.